BridgeBio Pharma
BBIO
#2229
Rank
HK$51.93 B
Marketcap
HK$273.08
Share price
-3.54%
Change (1 day)
12.85%
Change (1 year)

BridgeBio Pharma (BBIO) - Cash on Hand

Cash on Hand as of December 2024 : HK$5.29 Billion

According to BridgeBio Pharma 's latest financial reports the company has HK$5.29 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

BridgeBio Pharma - Cash on Hand chart (from 2018 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31HK$5.28 B55.68%
2023-12-31HK$3.39 B-7.89%
2022-12-31HK$3.68 B-43.48%
2021-12-31HK$6.52 B38.62%
2020-12-31HK$4.70 B10.68%
2019-12-31HK$4.25 B24.52%
2018-12-31HK$3.41 B375.12%
2017-12-31HK$0.71 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
HK$0.12 B-97.59%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$3.35 B-36.58%๐Ÿ‡บ๐Ÿ‡ธ USA